Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C. Koike is active.

Publication


Featured researches published by C. Koike.


Xenotransplantation | 1996

Introduction of α(1,2)‐fucosyltransferase and its effect on a‐Gal epitopes in transgenic pig

C. Koike; Reiji Kannagi; Yoshihiro Takuma; Fumiko Akutsu; Satoshi Hayashi; Nozomu Hiraiwa; Kenji Kadomatsu; Takashi Muramatsu; Hirohito Yamakawa; Takuya Nagai; Shoji Kobayashi; Hidechika Okada; Izumi Nakashima; Kazuharu Uchida; Itsuo Yokoyama; Hiroshi Takagi

Abstract: Hyperacute rejection (from pig to human) is thought to result from activation of complement initiated by the binding of host natural antibodies to α‐galactosyl (α‐Gal) epitopes of donor endothelial cells. However, α‐Gal epitope shares a common precursor with H antigen in humans. This means that H antigens as well as α‐Gal epitopes are synthesized in a competitive manner by different enzymes. We thought that it would be possible to convert α‐Gal epitopes into H antigens by introducing cDNA of α(1,2)‐fucosyltransferase (α1–2FT) into porcine cells, and so, pig embryos were microinjected with αl‐2FT cDNA. Transgenic pigs that carried α1–2FT were thus established. Cytotoxicity of fibrocytes derived from skin of transgenic pig was measured by 51Cr release assay, which showed that H antigen‐expressing cells were significantly resistant to a challenge with human sera. These experiments indicate that our method provides a new strategy which contributes to a successful discordant xenotransplantation.


Xenotransplantation | 1997

Direct gene replacement of the mouse α(1,3)-galactosyltransferase gene with human α(1,2)-fucosyltransferase gene: Converting α-galactosyl epitopes into H antigens

C. Koike; Akio Katayama; Kenji Kadomatsu; Takashi Muramatsu; Nozomu Hiraiwa; Reiji Kannagi; Izumi Nakashima; Itsuo Yokoyama; Hiroshi Takagi

Abstract: The chronic donor organ shortage has led to the production of transgenic animals. We assume that cells or organs derived from possible animal donors carrying a large amount of α‐galactosyl epitopes should not be transplanted into humans, because a corresponding amount of immunosuppressants would be needed to prolong the survival of such xenografts in the recipients. This may not only make the recipients compromised hosts but also introduce some unknown or uncontrollable pathogens into society at large. We also assume that gene manipulation itself should not be a detriment to possible transgenic animals. To explore possibilities that not only can minimize the possible detrimental factors to humans, such as α‐galactosyl epitopes, but also can minimize the possible detriment to transgenic animals, such as random integration of the extraneous genes with or without uncontrollable regulatory sequences, we have produced a DNA construct that replaces the mouse oc(1,3)‐galactosyltransferase gene (GT) with the human a(1,2)‐fucosyltransferase (FT) minigene (promoterless for the expression of FT) at the GT locus. The mouse fibrosarcoma cell line, L929, was transfected with the construct. Colonies were obtained after incubation with non‐heat‐inactivated human serum. Southern blot analysis demonstrated that one allele of the mouse GT gene was replaced with the FT minigene at the GT locus without integration of any selectable marker genes. The immunostaining analysis with lectins showed that the transfectants expressed H antigens, which suggested that H antigens were expressed by the intrinsic GT promoter. Thus gene replacement, knock‐in, of the mouse GT with the human FT without integration of any selectable marker genes in the GT locus was shown to be possible. This is especially important in producing transgenic animals for the clinical application of xenografts into humans.


Surgery Today | 1996

Establishment of a human DAF/HRF20 double transgenic mouse line is not sufficient to suppress hyperacute rejection

C. Koike; Ken-ichi Isobe; Izumi Nakashima; Hidechika Okada; Shuji Hayashi; Itsuo Yokoyama; Hiroshi Takagi

To solve the chronic donor organ shortage, the pig is considered to be a possible donor candidate for human transplantation. However, hyperacute rejection occurs due to the activation of the complement cascade. Therefore, the introduction of human complement inhibitors into animal cells has been proposed as a means to prevent such exologous complement activation. To investigate the extent to which complement inhibitors are resistant to human sera in discordant animals, we established transgenic mice lines which expressed either human decay-accelerating factor (DAF) and/or homologous restriction factor 20 (HRF20) using microinjection methods. Human sera were injected into (a) 10 control mice, (b) 10 DAF-transgenic mice, (c) 10 HRF20-transgenic mice, and (d) 10 DAF and HRF20-transgenic mice. The results showed that all the mice in groups a, b, and c died immediately after injection. Three of the mice in group d died, while seven survived but showed hyperpnea and low activity. The pathological findings of groups a, b, and c included severe coagulation; however, the survivors of group d showed less severe symptoms. The above findings thus suggest that both DAF and HRF20 tend to prevent complement activation to some extent; however, its effectiveness is not considered to be sufficient for clinical use in transplantation.


Transplantation Proceedings | 1997

Reduction of α-Gal epitopes in transgenic pig by introduction of human α1–2 fucosyltransferase

C. Koike; Akio Katayama; Kenji Kadomatsu; N. Hiraiwa; Shuji Hayashi; Takaaki Kobayashi; S. Hayash; Itsuo Yokoyama; Hiroshi Takagi


Transplantation Proceedings | 1998

TAP1, TAP2, LMP2, DMA, and DMB genetic polymorphisms in renal transplantation

Takaaki Kobayashi; Itsuo Yokoyama; Shuji Hayashi; Masataka Negita; Namil Y; Akio Katayama; Takaharu Nagasaka; C. Koike; Y. Tachi; Mei Gl; Toshihito Haba; Yoshihiro Tominaga; Naruse T; Hidetoshi Inoko; Koji Uchida; Hiroshi Takagi


Transplantation Proceedings | 1997

Hepatocyte apoptosis and cytosolic calcium dynamics in ischemic injury.

Itsuo Yokoyama; Shuji Hayashi; Takaaki Kobayashi; Masataka Negita; Y Namii; Akio Katayama; Takaharu Nagasaka; C. Koike; Y. Tachi; Akemi Hayakawa; H. Tajiri; Hiroshi Takagi


Transplantation Proceedings | 1997

Marginal kidney graft function from non-heart-beating donors

Itsuo Yokoyama; Koji Uchida; Shuji Hayashi; Takaaki Kobayashi; Masataka Negita; Y Namii; Akio Katayama; Takaharu Nagasaka; C. Koike; Y. Tachi; K. Morozumi; Akira Orihara; M. Numano; Hiroshi Takagi


Transplantation Proceedings | 1997

Adenovirus-mediated gene transfer to the xenogeneic liver in liver xenotransplantation: the transduction of complement regulatory factor genes (DAF and HRF20).

Shuji Hayashi; C. Koike; Y Namii; Takaharu Nagasaka; Akio Katayama; Izumu Saito; H. Okada; Itsuo Yokoyama; S. Ohtsuka; Koji Uchida; Hiroshi Takagi


Transplantation Proceedings | 1997

Effect of antisense ribozyme to alpha (1,3)galactosyl transferase gene on the expression of Gal alpha (1,3)Gal epitope.

Shuji Hayashi; Takaharu Nagasaka; C. Koike; Takaaki Kobayashi; Hirofumi Hamada; Itsuo Yokoyama; Izumu Saito; Hiroshi Takagi


Transplantation Proceedings | 1998

Inhibitory effect of α(1,2) fucosyltransferase recombinant adenoviral vector on αGal expression

Takaharu Nagasaka; Shuji Hayashi; Y. Tachi; D.-K. Liu; C. Koike; Y Namii; Akio Katayama; Masataka Negita; Takaaki Kobayashi; Hirofumi Hamada; Itsuo Yokoyama; Hiroshi Takagi

Collaboration


Dive into the C. Koike's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akio Katayama

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge